molecular physiology and biophysics Archives

Alyssa Hasty, PhD, left, Jeffrey Rathmell, PhD, and Kamran Idrees, MD, MSCI, are part of a multidisciplinary team that received a 2023 Endeavor Award from The Mark Foundation for Cancer Research to study the connection between obesity and cancer. Team members not pictured include Kathryn Wellen, PhD, Liza Makowski, PhD, and Kathryn Beckermann, MD, PhD.

Vanderbilt-led team receives 2023 Endeavor Award from The Mark Foundation for Cancer Research

Oct. 24, 2023—A multidisciplinary team of investigators has received a 2023 Endeavor Award from The Mark Foundation for Cancer Research to support four closely linked projects exploring the fundamental mechanisms that drive the obesity-cancer connection,

The team studying how to control sepsis in the lungs and kidneys includes, from left, Huan Qiao, MD, PhD Jacek Hawiger, MD, PhD, Jozef Zienkiewicz, PhD, and Yan Liu, MD, MS. (photo by Erin O. Smith)

Study reveals genomic code for sepsis in the lungs and kidneys

Aug. 21, 2023—Researchers at Vanderbilt University Medical Center and the Nashville Veterans Affairs Medical Center have “cracked” the genomic code for sepsis in the lungs and kidneys.

Vanderbilt’s Rafael Arrojo e Drigo, PhD, right, recently received a young investigator award named in honor of the scientist to his left, Robert Sorenson, PhD, professor emeritus at the University of Minnesota

Arrojo e Drigo receives award for excellence in the field of islet research

Jul. 5, 2023—Vanderbilt's Rafael Arrojo e Drigo, PhD, recently received the inaugural Robert L. Sorenson Young Investigator Award from the Midwest Islet Club (MIC) in recognition of his research excellence and innovation in the field of islet research.

Delpire recognized for advancing cell and molecular physiology

Apr. 12, 2023—Vanderbilt's Eric Delpire, PhD, has been awarded the 2023 Davson Distinguished Lectureship, the highest award bestowed by the Cell and Molecular Physiology Section of the American Physiological Society.

Attending last week’s Discovery Lecture by Nobel laureate Sir Paul Nurse, PhD, (fourth from left) were, from left, Jackie Corbin, PhD, Kathy Gould, PhD, Sharron Francis, PhD, Nancy Carrasco, MD, and Roger Colbran, PhD.

Sir Paul Nurse Discovery Lecture

Feb. 16, 2023—Among those attending last week’s Discovery Lecture by Nobel laureate Sir Paul Nurse, PhD, were, Jackie Corbin, PhD, Kathy Gould, PhD, Sharron Francis, PhD, Nancy Carrasco, MD, and Roger Colbran, PhD.

Nobel laureate Nurse set for year’s first Discovery Lecture

Jan. 26, 2023—Nobel Prize-winning geneticist and cell biologist Sir Paul Nurse, PhD, will be at Vanderbilt Thursday, Feb. 9, to deliver the year's first Discovery Lecture.

The study could suggest ways to promote the transport of phospholipids and cholesterol out of macrophages, immune system cells that play key roles in all stages of atherosclerosis development.

Study points to new ways to prevent, treat heart disease

Jan. 19, 2023—Vanderbilt researchers have confirmed the existence of an alternative pathway to atherosclerosis, a finding that may lead to new ways to prevent and treat cardiovascular disease.

Vanderbilt mourns loss of renowned scientist Exton

Dec. 28, 2022—John H. Exton, MBChB, MD, PhD, professor of Molecular Physiology and Biophysics, emeritus at Vanderbilt University, whose research provided fundamental insights into how many biologically active compounds control cellular physiology, died Dec. 18. He was 89.

Study explores possible drug target for neurological problems

Nov. 3, 2022—A team at Case Western Reserve University and Vanderbilt University Medical Center has determined with atomic-level precision how two established drugs bind to and alter the conformation of a cell membrane transporter protein called NKCC1, shutting down its activity.

Meena Madhur, MD, PhD, Matthew Alexander, MD, PhD, and colleagues are studying how a common genetic change impacts the development of inflammation and high blood pressure.

Study sheds light on the development of inflammation, high blood pressure and resulting kidney damage

Oct. 20, 2022—by Bill Snyder Researchers at Vanderbilt University Medical Center have found that the change in a single letter of the genetic code promotes, in a mouse model, the development of inflammation, high blood pressure and resulting kidney damage. Their findings, featured Oct. 14 on the cover of Circulation Research, suggest that targeting inflammatory cytokines, signaling...

Hodges, Nakagawa receive Cohen Innovation funds

Sep. 14, 2022—Emily Hodges, PhD, assistant professor of Biochemistry, and Terunaga Nakagawa, MD, PhD, associate professor of Molecular Physiology and Biophysics, were named as the 2022 recipients of Stanley Cohen Innovation Funds

Pozzi elected president of Society for Matrix Biology

Jan. 20, 2022—Vanderbilt's Ambra Pozzi, PhD, has been elected president of the American Society for Matrix Biology (ASMB), a scientific organization that promotes research on the extracellular matrix with the aim of improving human health.